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http://dx.doi.org/10.1016/j.pedneo.2Background: All-trans retinoic acid (ATRA) induces in vitro angiogenesis and vascular endothe-
lial growth factor (VEGF) secretion. Prenatal administration of vitamin A tends to increase the
pulmonary and plasma levels of VEGF in the developing mouse. The aims of this study were to
examine the effects of maternal retinoic acid treatment on lung VEGF expression and angio-
genesis in oligohydramnios-exposed fetal rats.
Methods: On day 16 of gestation, pregnant SpragueeDawley rats were randomly assigned to
either the retinoic acid group (intragastric ATRA at 10 mg/kg body weight) or the vehicle
group. We punctured each uterine sac to produce oligohydramnios, and fetuses in the opposite
uterine horn served as controls. On day 21 of gestation, the fetuses were delivered by cesarean
section.
Results: Rats exposed to oligohydramnios exhibited lower lung weights and lung/body weight
ratios, and ATRA exhibited no effects on the body or lung weights of oligohydramnios-exposed
rats. Lung microvessel density decreased in oligohydramnios-exposed rats of maternal vehicle-
treated dams. Microvessel density was comparable between the oligohydramnios þ retinoic
acid group and the control þ retinoic acid group. VEGF expression was comparable among
control and oligohydramnios-exposed rats of maternal vehicle- or retinoic acid-treated dams.
Conclusion: Maternal retinoic acid treatment did not increase lung VEGF expression or
enhance lung development in oligohydramnios-exposed fetal rats. These results do not supportof Pediatrics, Taipei Medical University Hospital, 252, WuXing Street, Taipei, Taiwan.
.tw (C.-M. Chen).
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Maternal retinoic acid and fetal lung angiogenesis 89the use of maternal retinoic acid to prevent oligohydramnios-induced pulmonary hypoplasia in
the pseudoglandular stage.
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reserved.1. Introduction
Oligohydramnios may retard fetal lung growth and can result
in pulmonary hypoplasia in experimental animals and in
human fetuses with prolonged rupture of the membrane.1,2
The fluid maintains the lungs in an expanded state and
provides the tissue with themechanical stretching necessary
for normal lung development.3 We found that experimental
oligohydramnios decreases platelet-derived growth factor
expression and epithelial tubules and saccules counts in
hypoplastic fetal rat lungs.4 Vascular endothelial growth
factor (VEGF) is a potent endothelial cell mitogen that
regulates endothelial cell differentiation and angiogen-
esis.5,6 Angiogenesis is physiologically important for alveo-
larization during normal lung development.7 The effect of
oligohydramnios on lung angiogenesis remains unknown. We
hypothesized that experimental oligohydramnios induced
defective angiogenesis and decreased VEGF expression in
hypoplastic fetal rat lungs.
Vitamin A supplementation is anticipated to improve
alveolar formation through its effects on expression of
growth factors in the lung that participate in alveolar
capillary growth. The rationale for vitamin A supplementa-
tion is that vitamin A and its downstream metabolites, such
as all-trans retinoic acid (ATRA), increase VEGF and VEGF-
receptor expression in the lung and maintain alveolar
development in mice treated with an angiogenesis inhib-
itor.8e10 The aims of this study were to examine the effects
of maternal retinoic acid treatment on lung VEGF expression
and angiogenesis in oligohydramnios-exposed fetal rats.
2. Materials and Methods
2.1. Experimental design and animal model
This study was approved by the Animal Care and Use
Committees of Taipei Medical University and was performed
using timed pregnant SpragueeDawley rats. Five pregnant
damswere used for this study. Pregnant damswere randomly
assigned to either the retinoic acid group (n Z 3) or the
vehicle group (nZ 2) on gestational day 16. Each pregnant
dam in the retinoic acid group or vehicle group was given
a single dose of 3 mL ATRA (10 mg/kg body weight; Sigma, St.
Louis, MO, USA) or an equal volume of the vehicle solution
(ethanol/olive oil/water in 1:1:1 by volume) by an intra-
gastric route without anesthesia. ATRA was administered on
day 16 of gestation to precede the period when the fetal rat
lung retinyl palmitate concentration rapidly increases to
a peak on gestational day 17.11 The dosage was based on
a study by Shenai and Chytil,12 who reported that a single
dose of retinyl palmitate by maternal intragastric adminis-
tration on gestational day 16 led to a significant increase in
fetal lung retinyl esters within 24 h, and that the effectpersisted until postnatal day 14. The dams were anes-
thetized with pentobarbital (50 mg/kg, i.p.) 1 hour after
intragastric retinoic acid or vehicle administration. An
abdominal midline incision was made, and the two uterine
horns were exposed and kept moist with normal saline. The
uterine wall and fetal membranes of each uterine sac in one
horn were punctured using a 19-gauge needle, which resul-
ted in an immediate visible leakage of amniotic fluid and
a decrease in the size of the uterine sac. Fetuses in the
opposite uterine horn served as controls. The uterus was
returned to the abdomen, and the abdominal incision was
repaired in two layers with silk sutures. The dam was placed
in an isolated cage and allowed to recover. On day 21 of
gestation, the dams were anesthetized with pentobarbital
(50 mg/kg, i.p.), and the fetuses were delivered by cesarean
section. The fetuses were weighed and killed by pentobar-
bital (100 mg/kg, i.p.); then, a ventral midline incision was
made, the lungs were dissected free and weighed, and
results were expressed as the ratio (%) of lung/body weights.
2.2. Morphological analysis
The lungs were removed and fixed in 10% neutral buffered
formalin. Lung sections were cut at 4-mm thickness and
stained with hematoxylin and eosin to observe the general
morphology. Five portions of every section were randomly
selected and captured at 200 magnifications, and then
analyzed using the computerized image analysis system
(Image-Pro Plus 5.1 for Windows; Media Cybernetics, Inc.,
Bethesda, MD, USA) to examine the septal thickness.13
Digitized images from four nonoverlapping fields of each
section were captured. Then, images were printed and
examined. The number of points that fell on the airspacewas
counted by superimposing the transparent grids (196 points)
onto the enlarged printed images. All points falling on the
component were counted from the nonoverlapping fields of
view until all sections from each animal were counted.
Airspace volume fraction was defined as the number of
points falling on airspace divided by the total number of test
points.14
2.3. Microvessel density and
immunohistochemistry of VEGF
The right superior lobe was embedded in paraffin, and 7-mm
sections were cut for histochemical analysis. After depar-
affinization in xylene and rehydration in an alcohol series,
the sections were first preincubated for 1 hour at room
temperature in 0.1M phosphate-buffered saline containing
10% normal goat serum and 0.3% H2O2 to block endogenous
peroxidase activity and nonspecific binding of antibody
before being incubated for 20 hours at 4C with rabbit
polyclonal antibody von Willebrand factor (vWF; 1:200,
90 C.-M. Chen et alDako, Carpinteria, CA, USA) and rabbit polyclonal antibody
VEGF (1:200, Santa Cruz Biotechnology, Inc., CA, USA). The
sections were then treated for 1 hour at room temperature
with biotinylated goat antirabbit IgG (1:200, Vector, CA,
USA). This was followed by the reaction with the reagents
from an ABC kit (AvidineBiotin Complex; Vector Laborato-
ries, Burlingame, CA, USA) as per the manufacturer’s
recommendations. Microvessel density was determined by
counting the vessels staining positively for vWF at 200
magnifications.15 For VEGF quantification, a minimum of
four random lung fields of immunohistochemistry-stained
sections per animal at 200 magnifications were captured
with a digital camera and imported into the computerized
image analysis system Image-Pro Plus.16 The automatic
object counting and measuring process was used to quantify
the immunoreactivity in the sections. This generated
a percentage of positively stained cells and the values were
expressed as labeling index (%).
2.4. Statistical analysis
Results are presented as the mean  SD. The analysis of
difference among multiple groups was carried out using
one-way analysis of variance, and significance was deter-
mined using Bonferroni correction for multiple compari-
sons. Differences were considered significant at p < 0.05.
3. Results
3.1. Body weight, lung weight, and the lung/body
weight ratio (%)
The effects of oligohydramnios and maternal retinoic acid
treatment on the fetal body weight, lung weight, and lung/
body weight ratio (%) are presented in Table 1. Rats exposed
to oligohydramnios exhibited significantly lower lungweights
and lung/body weight ratios when compared with their
control littermates. Maternal retinoic acid treatment had no
effects on the body or lung weights of oligohydramnios-
exposed rats. Maternal retinoic acid treatment significantly
increased the body weight of the control rats compared to
control rats of maternal vehicle-treated dams.
3.2. Morphological analysis
The histological appearances of hematoxylin and eosin-
stained lungs are illustrated in Figure 1. The representativeTable 1 Body weight, lung weight, and the lung/body weight r
Treatment Body weight
Control þ vehicle 7 3.75  0.22
Oligohydramnios þ vehicle 5 3.38  0.35
Control þ retinoic acid 7 4.06  0.27
Oligohydramnios þ retinoic acid 9 3.78  0.36
* p < 0.05, compared with the control þ vehicle group.
y p < 0.01, compared with the control þ vehicle group.
z p < 0.05, compared with the control þ retinoic acid group.
x p < 0.01, compared with the control þ vehicle and control þ retlung sections exhibit a thicker interstitium and fewer
saccules in oligohydramnios-exposed rats in the maternal
vehicle- or retinoic acid-treated groups (Figure 1A). Volume
fractions of the airspace were significantly lower, and
septal thickness was significantly greater in the
oligohydramnios þ vehicle and oligohydramnios þ retinoic
acid groups compared with control animals (Figure 1B).
Volume fractions and septal thickness of the airspace were
comparable between the control þ vehicle group and the
control þ retinoic acid group.
3.3. Microvessel density
To explore angiogenesis in the lung, we performed immu-
nohistochemical staining using an antibody (vWF), a specific
marker for endothelial cells. In oligohydramnios-exposed
animals, the microvascular density per field of lung tissue
tended to be lower compared with that of
the controlþ vehicle group (Figure 2, pZ 0.086). Microvessel
density in the oligohydramnios þ retinoic acid group was
similar with that in the control þ retinoic acid group.
3.4. Immunohistochemistry of VEGF
Immunoreactivities of VEGF were mainly detected in airway
epithelial cells and some mesenchymal cells, and the
immunoreactivity was comparable among the four groups
(Figure 3).
4. Discussion
The effects of maternal retinoic acid treatment on VEGF
expression and lung angiogenesis in oligohydramnios-
exposed fetal rats are largely unknown. In the present
study, the late gestational exposure of fetal rats to oligo-
hydramnios for 5 days decreased fetal lung angiogenesis and
had no effect on VEGF expression. Concomitant maternal
retinoic acid treatment at a dose of 10 mg/kg did not
increase VEGF expression or enhance fetal lung angiogen-
esis. We have found that maternal retinoic acid treatment
increased platelet-derived growth factor-A and -B mRNA
expression in oligohydramnios-exposed fetal rat lungs but
did not enhance fetal lung development.17 The present study
further suggests that the development of pulmonary vascu-
lature is complex, and that other angiogenic factors are
involved in regulating fetal lung angiogenesis.18
Literature reports support the use of rodents for
studying oligohydramnios because their relative timing ofatio in control and oligohydramnios-exposed rats.
(g) Lung weight (g) Lung/body weight (%)
0.11  0.01 3.06  0.20
0.08  0.02x 2.37  0.53*
y 0.12  0.01 2.95  0.26
0.09  0.01z 2.52  0.36*
inoic acid groups.
Figure 1 (A) Representative photomicrographs (200) and (B) volume fractions and septal thickness of the airspace in the lung
sections. Oligohydramnios-exposed rats exhibited a thicker interstitium, fewer and less-advanced saccules, and fewer bronchial
passageways when compared with control animals. Volume fractions and septal thickness of the airspace were comparable
between the control þ vehicle group and control þ retinoic acid groups. Volume fractions of the airspace were significantly lower
and septal thickness was significantly greater in the oligohydramnios þ vehicle and oligohydramnios þ retinoic acid groups
compared with control groups. ***p < 0.001, **p < 0.01, compared with the control þ vehicle and control þ retinoic acid groups.
Maternal retinoic acid and fetal lung angiogenesis 91alveolarization resembles human lung development.19
Oligohydramnios may retard fetal lung growth and result in
pulmonary hypoplasia.2 Pulmonary hypoplasia was defined as
underdevelopment of the lungs with a low lung weight for
a given body weight. In the present study, we did producepulmonary hypoplasia based on lung weight and lung/body
weight ratio and histological findings of less airway
generation.
In this study, maternal retinoic acid treatment had no
effects on the lungweights of control rats, but it significantly
Figure 2 (A) Representative photomicrographs and (B) mean microvessel density in the lung tissues (200). Microvessel density
was determined by counting vessels staining positively for von Willebrand factor. Arrows indicate positively stained microvessels
(brown). Microvessel density presented as mean counts per field of view.
92 C.-M. Chen et alincreased the body weights of control rats compared to
control rats of maternal vehicle-treated dams. These data
are consistent with those of Antipatis et al,20 who demon-
strated that a single dose of prenatal retinyl acetate to
vitamin A-sufficient pregnant rats on day 10 of gestation
increased the body weight of fetuses delivered on day 20 of
gestation, and Baptista et al,21 who found that a late ante-
natal administration of vitamin A on day 18.5 of gestation did
not affect the lung growth of fetuses delivered on day 22 of
gestation.
Pulmonary vascular development is a complex biological
process that includes vasculogenesis, the de novo organiza-
tion of blood vessels by differentiation of endothelial cells
from mesoderm, and angiogenesis, the budding and
branching of new vessels from preexisting vessels.22 This
complex and highly organized process requires a delicate
orchestration of the regulatory activity of multiple growth
factors in a specific temporospatial order. Recent studies
suggest that inadequate pulmonary vascular development
may lead to underdeveloped airways and gas exchangeunits.7,23 Defective angiogenesis has been recognized in
hypoplastic lungs in human and in animal models of
congenital diaphragmatic hernia.24 However, lung angio-
genesis has rarely been reported in oligohydramnios-
associated lung hypoplasia. Microvessel density is a marker
of angiogenesis that has been used extensively in the onco-
logic literature to document the metastatic potential of
tumors.25 VEGF is a potent endothelial cell mitogen that
regulates endothelial cell differentiation and angiogen-
esis.5,6 VEGF is essential for embryogenesis, asmice deficient
in VEGF-A have severe vascular defects that are lethal by
embryonic day E8.5 to E9.26,27 Retinoic acid has been shown
to induce VEGF secretion/mRNA expression in human
umbilical vein endothelial cells, and prenatal administration
of vitamin A tends to increase pulmonary and plasma levels of
VEGF in the developing mouse.8,9 In our rat model, micro-
vessel density tends to be lower in the oligohydramnios-
exposed fetal rats, and VEGF protein expression was
comparable among control and oligohydramnios-exposed
rats of maternal vehicle- or retinoic acid-treated dams.
Figure 3 (A) Immunohistochemical staining for vascular endothelial growth factor (VEGF) (200) and (B) quantitative analysis of
VEGF immunoreactivity in the lung sections. Positive staining is shown as brown (arrow). Immunoreactivities of VEGF were mainly
detected in airway epithelial and some mesenchymal cells.
Maternal retinoic acid and fetal lung angiogenesis 93ATRA did not increase VEGF expression and failed to stimu-
late lung angiogenesis as measured by microvessel density.
These outcomes are likely to be related to differences in the
stage of lung development and the timing and duration of the
administration of ATRA.
In conclusion, this study shows that experimental oli-
gohydramnios on day 16 of gestation produces pulmonary
hypoplasia and tends to retard angiogenesis on day 21 of
gestation in fetal rats. Maternal retinoic acid treatment did
not increase lung VEGF expression, and it did not exert
positive effects on pulmonary hypoplasia induced by oli-
gohydramnios. This study does not support the use of
maternal retinoic acid to prevent or ameliorate
oligohydramnios-induced pulmonary hypoplasia in the
pseudoglandular stage. Further study is required to deter-
mine the effects of the dose and timing of administration
of retinoic acid on oligohydramnios-induced pulmonary
hypoplasia.References
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